Skip to main content
SpringerLink
Log in
Book cover

Office Andrology pp 169–181Cite as

Strategic Therapies for Ejaculatory Disorders and Erectile Dysfunction in the Infertile Man

  • Chapter

  • 641 Accesses

Part of the book series: Contemporary Endocrinology ((COE))

Abstract

Although ejaculatory disorders and erectile dysfunction (ED) are rare causes of male infertility, these conditions may challenge both the couples’ determination and physicians’ ingenuity. Dubin and Amelar reported that 2% of men presenting for infertility evaluation are diagnosed with ejaculatory dysfunction (1), many of which require specialized treatment (2,3). The spectrum of clinical presentations includes premature ejaculation, retarded ejaculation, anejaculation, and retrograde ejaculation. Premature ejaculation is the most common ejaculatory dysfunction, affecting up to 70% of normal men at some point in their active sexual life (2,3). ED, defined as the inability to attain or maintain penile erection for satisfactory sexual intercourse, is a global health problem with increasing recognition (4). Men who suffer from ED and infertility can be more difficult to treat than men who suffer from either condition alone.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Dubin L, Amelar RD. Etiologic factors in 1294 consecutive cases of male infertility. Fertil Steril 1971; 22:469–474.

    PubMed  CAS  Google Scholar 

  2. McMahon CG, Samali R. Pharmacological treatment of premature ejaculation. Curr Opin Urol 1999;9: 553–561.

    Article  PubMed  CAS  Google Scholar 

  3. Jannini EA, Simonelli C, Lenzi A. Disorders of ejaculation. J Endocrinol Invest 2002;25: 1006–1019.

    PubMed  CAS  Google Scholar 

  4. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical psychosocial correlates: results of the Massachusetts male aging study. J Urol 1994;151:54–61.

    PubMed  CAS  Google Scholar 

  5. Newman HF, Reiss H, Northrup JD. Physical basis of emission, ejaculation, and orgasm in the male. Urology 1991;19:341–350.

    Article  Google Scholar 

  6. Schuster TG, Ohl DA. Diagnosis and treatment of ejaculatory dysfunction. Urol Clin N Am 2002;29: 939–948.

    Article  Google Scholar 

  7. Screponi E, Carosa E, DrStasi SM, et al. Prevalence of chronic prostatitis in men with premature ejaculation. Urology 2001;58:198–202.

    Article  PubMed  CAS  Google Scholar 

  8. Metz ME, Pryor JL. Premature ejaculation: a psychophysiological approach for assessment and management. J Sex Marital Ther 2000;26:293–320.

    Article  PubMed  CAS  Google Scholar 

  9. Masters WH, Johnson VE. Human sexual inadequacy. Little, Brown & Co., Boston, MA, 1970.

    Google Scholar 

  10. Waldinger MD. The neurobiological approach to premature ejaculation. J Urol 2002;168: 2359–2367.

    Article  PubMed  Google Scholar 

  11. Cooper A, Magnus R. A clinical trial of the beta blocker propranolol in premature ejaculation. J Psychsom Res 1984;28:331–336.

    Article  CAS  Google Scholar 

  12. Spiess WF, Geer JH, O’Donohue WT. Premature ejaculation: investigation of factors in ejaculatory latency. J Abnorm Psychol 1984;93:242–245.

    Article  PubMed  CAS  Google Scholar 

  13. Strassberg GS, Mahoney JM, Schaugaard M, Hale VE. The role of anxiety in premature ejaculation: a psychophysiological model. Arch Sex Behav 1990;19:251–258.

    Article  PubMed  CAS  Google Scholar 

  14. Shover LR, Friedman JM, Weiler SJ, et al. Multiaxial problem-oriented system for sexual dysfunction. Arch Gen Psych 1982;39:614–619.

    Google Scholar 

  15. Colpi GM, Fanciulacci F, Beratta G, et al. Evoked sacral potentials in subjects with true premature ejaculation. Andrologia 1986;18:583–586.

    Article  PubMed  CAS  Google Scholar 

  16. Fein RL. Intracavernous medication for treatment of premature ejaculation. Urology 1990;35: 301–303.

    Article  PubMed  CAS  Google Scholar 

  17. Seftel AD, Althof SE. Rapid ejaculation. Curr Urol Rep 2000;1:302–306.

    Article  PubMed  CAS  Google Scholar 

  18. Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J Clin Psychopharmacol 1998;18:274–281.

    Article  PubMed  CAS  Google Scholar 

  19. McMahon CG. Treatment of premature ejaculation with sertraline hydrochloride. Int J Imp Res 1998;10: 181–184.

    Article  CAS  Google Scholar 

  20. Chen J, Mabjeesh NJ, Matzkin H, et al. Efficacy of sildenafil as adjuvant therapy to selective serotonine reuptake inhibitor in alleviating premature ejaculation. Urology 2003;61:197–200.

    Article  PubMed  Google Scholar 

  21. Salonia A, Maga T, Colombo R, et al. A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. J Urol 2002;168:2486–2489.

    Article  PubMed  CAS  Google Scholar 

  22. Althof SE, Levine EB, Corty EW, et al. A double-blind crossover trial of clomipramine for rapid ejaculation in 15 couples. J Clin Psychiatry 1995;56:402–407.

    PubMed  CAS  Google Scholar 

  23. Choi HK, Jung GW, Moon KH, et al. Clinical study of SS-cream in patients with lifelong premature ejaculation. Urology 2000;55:257–261.

    Article  PubMed  CAS  Google Scholar 

  24. Choi HK, Xin ZC, Choi YD, et al. Safety and efficacy study with various doses of SS-cream in patients with premature ejaculation in a double-blind, randomized, placebo controlled clinical study. Int J Imp Res 1999; 11: 261–264.

    Article  CAS  Google Scholar 

  25. Hovav Y, Kafka I, Horenstein E, et al. Prostaticmassage as a method for obtaining spermatozoa in men with psychogenic anejaculation. Fertil Steril 2000;74:184,185.

    Article  PubMed  CAS  Google Scholar 

  26. Okada H, Fujisawa M, Koshida M, et al. Ampullary, seminal vesicular, and prostatic massage for obtaining spermatozoa from patients with anejaculation. Fertil Steril 2001;75:1236,1237.

    Article  PubMed  CAS  Google Scholar 

  27. Wheeler Jr JS, Walter JS, Culkin DJ, et al. Idiopathic anejaculation treated by vibratory stimulation. Fertil Steril 1998;50:377–379.

    Google Scholar 

  28. Denil J, Kupker W, Al-Hasani S, et al. Succesful combination of transrectal ejaculation and intracytoplasmic sperm injection in the treatment of anejaculation. Hum Reprod 1996;11: 1247–1249.

    PubMed  CAS  Google Scholar 

  29. Thompson S, Honig S, Lipschultz LI. Sexual and ejaculatory dysfunction as a cause of male infertility. In: Infertility Evaluation and Treatment. Keye W, Rebar R, Chang R, Soules M, eds. WB Saunders, Philadelphia, PA, 1995, pp. 671–685.

    Google Scholar 

  30. Pryor JP, Hendry WF. Ejaculatory duct obstruction in subfertile males: analysis of 87 patients. Fertil Steril 1991;56:725–730.

    PubMed  CAS  Google Scholar 

  31. Dunsmir WD, Emberton. There is a significant sexual dysfunction following TURP. Br J Urol 1999; 22(Suppl. 1):39,40.

    Google Scholar 

  32. Ochsner MG, Burns E, Henry HH. Incidence of retrograde ejaculation following bladder neck revision as a child. J Urol 1970;104;596–597.

    PubMed  CAS  Google Scholar 

  33. Debruyne FM. Alpha blockers: are all created equal? Urology 2000;56(Suppl):20–22.

    Article  PubMed  CAS  Google Scholar 

  34. McCullough AR. Ejaculatory disorders. In: Mulcahy JJ, ed. Male Sexual Function. Humana Press Inc., Totowa, New Jersey, 2001, pp. 351–370.

    Chapter  Google Scholar 

  35. Bivalacqua TJ, Champion HC, Hellstrom WJG, Kadowitz PJ. Pharmacotherapy for erectile dysfunction. Trends Pharmacol Sci 2000;21:484–489.

    Article  PubMed  CAS  Google Scholar 

  36. Nehra A. Intracavernosal therapy: when oral agents fail. Curr Urol Rep 2001;2:468–472.

    Article  PubMed  CAS  Google Scholar 

  37. Saenz de Tejada I. In the physiology of erection, signposts to impotence. Contemp Urol 1992; 7: 52–68.

    Google Scholar 

  38. Andersson KE, Wagner G. Physiology of erection. Physiol Rev 1995;75:191–236.

    PubMed  CAS  Google Scholar 

  39. Burnett AL, Lowenstein CJ, Bredt DS, et al. Nitric oxide: a physiologic mediator of penile erection. Science 1992;257:401–403.

    Article  PubMed  CAS  Google Scholar 

  40. Rajfer J, Aronson WJ, Bush PA, et al. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med 1992;326:90–94.

    Article  PubMed  CAS  Google Scholar 

  41. Mulhall JP. Deciphering erectile dysfunction drug trials. J Urol 2003;170:353–358.

    Article  PubMed  Google Scholar 

  42. Rajpurkar A, Dhabuwala CB. Comparison of satisfaction rates and erectile function in patients treated with sildenafil, intracavernous prostaglandin E1 and penile implant surgery for erectile dysfunction in urology practice. J Urol 2003;170:159–163.

    Article  PubMed  CAS  Google Scholar 

  43. Kloner RA. Erectile dysfunction and cardiovascular risk factors. Hosp Prac 2001;36:41–51.

    Article  CAS  Google Scholar 

  44. Padma-Nathan H, Giuliano F. Oral drug therapy for erectile dysfunction. Urol Clin North Am 2001;28: 321–334.

    Article  PubMed  CAS  Google Scholar 

  45. Wysowski DK, Swann J. Use of medications for erectile dysfunction in the United States, 1986 through 2001. J Urol 2003;169:1040–1042.

    Article  PubMed  Google Scholar 

  46. Shabsigh R, Anastasiadis G. Erectile dysfunction. Annu Rev Med 2003;54:153–168.

    Article  PubMed  CAS  Google Scholar 

  47. Morales A, Gingell C, Collins M, et al. Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction. Int J Imp Res 1998;10:69–73.

    Article  CAS  Google Scholar 

  48. Leugwattanakij S, Flynn V, Hellstrom WJG. Intracavernosal injection and intraurethral therapy for erectile dysfunction. Urol Clin North Am 2001;28:343–354.

    Article  Google Scholar 

  49. Buvat J, Lemaire A, Marcolin G, et al. Intracavernous injection of papaverine: assessment of its diagnostic and therapeutic value in 100 impotent patients. World J Urol 1987;5:150.

    Article  Google Scholar 

  50. Porst H. The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience. J Urol 1996;155:802–815.

    Article  PubMed  CAS  Google Scholar 

  51. McMahon CG. A comparison of the response to the intracavernosal injection of a combination of papaverine and phentolamine, prostaglandin E1, and a combination of all three agents in the management of impotence. Int J Imp Res 1991;3:113.

    Google Scholar 

  52. Lefievre L, De Lamirande E, Gagnon C. The cyclic GMP-specific phosphodiesterase inhibitor, sildenafil, stimulates human sperm motility and capacitation but not acrosome reaction. J Androl 2000;21:929–937.

    PubMed  CAS  Google Scholar 

  53. Burger M, Sikka SC, Bivalacqua TJ, et al. The effect of sildenafil on human sperm motion and function from normal and infertile men. Int J Imp Res 2000;12:229–234.

    Article  CAS  Google Scholar 

  54. Andrade JR, Traboulsi A, Hussain A, Dubin N. In vitro effects of sildenafil and phentolamine, drugs used for erectile dysfunction, on human sperm motility. Am J Obstet Gynecol 2000;182: 1093–1095.

    Article  PubMed  CAS  Google Scholar 

  55. Hellstrom WJG, Overstreet JW, Yu A, et al. Tadalafil has no detrimental effect on human spermatogenesis or reproductive hormones. J Urol 2003, in press.

    Google Scholar 

  56. Hellstrom WJG, Wang R, Peterson CA, et al. Effects of alprostadil and prazosin on motility, viability and membrane integrity of human sperm. J Urol 1998;159:1559–1562.

    Article  PubMed  CAS  Google Scholar 

  57. Cookson MS, Nadig PW. Long term results with vacuum constriction device. J Urol 1993; 149: 290–294.

    PubMed  CAS  Google Scholar 

  58. Vrijhof HJEJ, Delaere KPJ. Vacom constriction devices in erectile dysfunction: acceptance and effectiveness in patients with impotence of organic and mixed etiology. Br J Urol 1994;74: 102–105.

    Article  PubMed  CAS  Google Scholar 

  59. Chen J, Mabjeesh NJ, Greenstein A. Sildenafil versus the vacuum erection device: patient preference. J Urol 2001;166:1779–1781.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Tulane University School of Medicine, New Orleans, LA

    Mustafa F. Usta MD & Wayne J. G. Hellstrom MD, FACS

Authors
  1. Mustafa F. Usta MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wayne J. G. Hellstrom MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynecology, Oregon Health and Science University, University Fertility Consultants, Portland, OR

    Phillip E. Patton MD  & David E. Battaglia PhD  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Usta, M.F., Hellstrom, W.J.G. (2005). Strategic Therapies for Ejaculatory Disorders and Erectile Dysfunction in the Infertile Man. In: Patton, P.E., Battaglia, D.E. (eds) Office Andrology. Contemporary Endocrinology. Humana Press. https://doi.org/10.1007/978-1-59259-876-2_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-876-2_11

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-318-3

  • Online ISBN: 978-1-59259-876-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation